Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.438.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.290SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.341SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.161SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.69 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.46SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.139SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.508SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.94SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.463SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.357SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.318SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.557SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.119SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.160SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
D.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.447SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.110.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.180SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.155SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.92SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.145SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.120SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.77SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AE.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.504SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AE.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.201SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.221SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.410SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.411SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.310SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.185SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.258.9SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
B.1.329SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.229SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.342SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.90SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.169SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
B.53SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.4.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.528SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.175SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.6.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.483SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.181SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.113SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.594SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.328SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.13SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used